Charles E. Alpers

1.0k total citations
17 papers, 812 citations indexed

About

Charles E. Alpers is a scholar working on Immunology, Nephrology and Molecular Biology. According to data from OpenAlex, Charles E. Alpers has authored 17 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Nephrology and 4 papers in Molecular Biology. Recurrent topics in Charles E. Alpers's work include Complement system in diseases (6 papers), Renal Diseases and Glomerulopathies (4 papers) and Renal and related cancers (2 papers). Charles E. Alpers is often cited by papers focused on Complement system in diseases (6 papers), Renal Diseases and Glomerulopathies (4 papers) and Renal and related cancers (2 papers). Charles E. Alpers collaborates with scholars based in United States, Austria and Brazil. Charles E. Alpers's co-authors include Richard J. Johnson, Donna M. Lombardi, David T. Denhardt, Cecilia M. Giachelli, Stephen M. Schwartz, William G. Couser, Masaomi Nangaku, Stuart J. Shankland, R. A. Willson and C. Stehman-Breen and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and American Journal Of Pathology.

In The Last Decade

Charles E. Alpers

15 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles E. Alpers United States 14 307 236 190 161 124 17 812
F M Lai Hong Kong 15 432 1.4× 174 0.7× 286 1.5× 177 1.1× 68 0.5× 30 874
G. Bánfi Italy 19 530 1.7× 292 1.2× 256 1.3× 104 0.6× 82 0.7× 40 1.1k
Giacomo Quattrocchio Italy 17 421 1.4× 259 1.1× 163 0.9× 115 0.7× 41 0.3× 52 836
Beatrice Coupes United Kingdom 16 331 1.1× 112 0.5× 68 0.4× 187 1.2× 22 0.2× 27 713
Brigitte McGregor France 18 253 0.8× 207 0.9× 69 0.4× 295 1.8× 83 0.7× 32 1.1k
Geneviève Depresseux Belgium 15 320 1.0× 78 0.3× 654 3.4× 219 1.4× 151 1.2× 23 1.1k
B. Hartley United Kingdom 16 423 1.4× 117 0.5× 130 0.7× 358 2.2× 26 0.2× 28 982
G. Mazzola Italy 14 158 0.5× 131 0.6× 77 0.4× 215 1.3× 26 0.2× 40 607
Akinari Sekine Japan 12 272 0.9× 129 0.5× 95 0.5× 57 0.4× 82 0.7× 113 667
Erasmia Psimenou Greece 22 282 0.9× 880 3.7× 159 0.8× 62 0.4× 67 0.5× 69 1.5k

Countries citing papers authored by Charles E. Alpers

Since Specialization
Citations

This map shows the geographic impact of Charles E. Alpers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Alpers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Alpers more than expected).

Fields of papers citing papers by Charles E. Alpers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Alpers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Alpers. The network helps show where Charles E. Alpers may publish in the future.

Co-authorship network of co-authors of Charles E. Alpers

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Alpers. A scholar is included among the top collaborators of Charles E. Alpers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Alpers. Charles E. Alpers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Paueksakon, Paisit, Behzad Najafian, Charles E. Alpers, & Agnes B. Fogo. (2025). AJKD Atlas of Renal Pathology: Lysozyme-Associated Nephropathy. American Journal of Kidney Diseases. 86(5). e1–e3.
2.
Schaub, Jennifer A., Steven Menez, Yumeng Wen, et al.. (2024). AKI in the Kidney Precision Medicine Project: Acute Tubular Injury vs. Acute Interstitial Nephritis. Journal of the American Society of Nephrology. 35(10S).
3.
Bracamonte, Erika, Nicolae Leca, Kelly D. Smith, et al.. (2007). Tubular Basement Membrane Immune Deposits in Association with BK Polyomavirus Nephropathy. American Journal of Transplantation. 7(6). 1552–1560. 36 indexed citations
4.
Mayer, Veronika, Kelly L. Hudkins, Holger Schmid, et al.. (2007). Expression of the chemokine receptor CCR1 in human renal allografts. Nephrology Dialysis Transplantation. 22(6). 1720–1729. 17 indexed citations
5.
Eitner, Frank, Yan Cui, Kelly L. Hudkins, et al.. (1999). Thrombotic Microangiopathy in the HIV-2-Infected Macaque. American Journal Of Pathology. 155(2). 649–661. 22 indexed citations
6.
Nangaku, Masaomi, Charles E. Alpers, Jeffrey W. Pippin, et al.. (1998). CD59 protects glomerular endothelial cells from immune-mediated thrombotic microangiopathy in rats.. Journal of the American Society of Nephrology. 9(4). 590–597. 73 indexed citations
7.
Nangaku, Masaomi, Charles E. Alpers, Stuart J. Shankland, et al.. (1997). Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9. Kidney International. 52(6). 1570–1578. 37 indexed citations
8.
Nangaku, Masaomi, Charles E. Alpers, Jeffrey W. Pippin, et al.. (1997). A new model of renal microvascular endothelial injury. Kidney International. 52(1). 182–194. 67 indexed citations
9.
Isik, F. Frank, Richard P. Rand, Joseph S. Gruss, David M. Benjamin, & Charles E. Alpers. (1996). Monocyte Chemoattractant Protein-1 mRNA Expression in Hemangiomas and Vascular Malformations. Journal of Surgical Research. 61(1). 71–76. 54 indexed citations
10.
Gallay, Brian, et al.. (1995). Glomerulonephritis in renal allografts associated with hepatitis C infection: A possible relationship with transplant glomerulopathy in two cases. American Journal of Kidney Diseases. 26(4). 662–667. 43 indexed citations
11.
Alpers, Charles E., Kelly L. Hudkins, Marina S. Ferguson, Richard J. Johnson, & Joe C. Rutledge. (1995). Platelet-derived growth factor A-chain expression in developing and mature human kidneys and in Wilms' tumor. Kidney International. 48(1). 146–154. 41 indexed citations
12.
Stehman-Breen, C., et al.. (1995). Hepatitis C virus associated membranous glomerulonephritis.. PubMed. 44(3). 141–7. 91 indexed citations
13.
Giachelli, Cecilia M., Donna M. Lombardi, David T. Denhardt, et al.. (1994). Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney International. 45(2). 515–524. 204 indexed citations
14.
Burdmann, Emmanuel A., Bridget Young, Takeshi F. Andoh, et al.. (1994). Mechanisms of cyclosporine-induced interstitial fibrosis.. PubMed. 26(5). 2588–9. 6 indexed citations
15.
Alpers, Charles E.. (1992). Immunotactoid (Microtubular) Glomerulopathy: An Entity Distinct From Fibrillary Glomerulonephritis?. American Journal of Kidney Diseases. 19(2). 185–191. 71 indexed citations
16.
Pruchno, Charles J., Matthias B. Schulze, Richard J. Johnson, et al.. (1991). Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis.. PubMed. 138(1). 203–11. 25 indexed citations
17.
Alpers, Charles E., Thomas L. Marchioro, & Richard J. Johnson. (1989). Monoclonal Immunoglobulin Deposition Disease in a Renal Allograft: Probable Recurrent Disease in a Patient Without Myeloma. American Journal of Kidney Diseases. 13(5). 418–423. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026